Mometasone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
Condition:   Nasal Polyposis Interventions:   Biological: Benralizumab 30 mg SC + Mometasone Furoate;   Biological: Matching placebo SC + Mometasone Furoate Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2018 Category: Research Source Type: clinical trials